News

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment

THE WOODLANDS, TX, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical…

1 year ago

MediWound to Report Second Quarter 2024 Financial Results

Conference Call and Webcast Scheduled for Wednesday, August 14th at 8:30 am Eastern TimeYAVNE, Israel, Aug. 02, 2024 (GLOBE NEWSWIRE)…

1 year ago

Harvard Bioscience Schedules Second Quarter 2024 Earnings Conference Call for August 8, 2024 at 10:00 AM ET

HOLLISTON, Mass., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the…

1 year ago

23andMe Special Committee responds to CEO’s take-private proposal

SOUTH SAN FRANCISCO, Calif., Aug. 02, 2024 (GLOBE NEWSWIRE) -- The Special Committee of the Board of Directors of 23andMe…

1 year ago

CVRx Announces Increased Inpatient Payment for Barostim Procedure

MINNEAPOLIS, Aug. 02, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that…

1 year ago

Immunovia files US patent application to protect its next-generation test

LUND, Sweden, Aug. 2, 2024 /PRNewswire/ -- Immunovia (Nasdaq Stockholm: IMMNOV), the pancreatic cancer diagnostics company, today announces the company…

1 year ago

Chronic Prostatitis or Pelvic Pain Syndrome Treatment with Dr Allen’s Device Safely Prevents Prostate Enlargement (BPH)

Thermobalancing therapy with Dr Allen's Device treats chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS) effectively and safely, helping to…

1 year ago

Hemostemix Closes its Funded Manufacturing Services Agreement with CytoImmune, Restarting Production of ACP-01

Calgary, Alberta--(Newsfile Corp. - August 1, 2024) - Hemostemix Inc. (TSXV: HEM) (OTC Pink: HMTXF) (FSE: 2VF0) is pleased to…

1 year ago

Axonics Reports Second Quarter 2024 Financial Results

Generated record revenue, gross margin and net income in 2Q24IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a medical technology company that…

1 year ago

SKNV Expands its Dermatology Customized Medications Service in Virginia, Maine, Vermont, and Arkansas

POMPANO BEACH, Fla., Aug. 1, 2024 /PRNewswire/ -- SKNV, an FDA-Registered 503B Outsourcing Facility currently serving over 4,000 dermatology providers with…

1 year ago